The impact of HIV treatment on risk behaviour in developing countries: A systematic review

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 6, 2007, Pages 707-720

  Kennedy, C ^a   O'Reilly, K ^b   Medley, A ^a   Sweat, M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTINENCE; ANTIVIRAL THERAPY; ARTICLE; CONDOM; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PATIENT CARE; PRIORITY JOURNAL; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL SUPPORT; SOCIOECONOMICS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS LOAD; VIRUS TRANSMISSION;

AFRICA; ANTI-RETROVIRAL AGENTS; DEVELOPING COUNTRIES; FEMALE; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; MALE; RISK-TAKING; SAFE SEX; SEX EDUCATION;

EID: 34250626541     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701203261     Document Type: Article

References (67)

1. Abadia-Barrero, C.E., & Castro, A. (2005). Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Social Science and Medicine, 62(5), 1219-28.
2. Akileswaran, C., Lurie, M.N., Flanigan, T.P., et al. (2005). Lessons learned from use of highly active antiretroviral therapy in Africa. Clinical Infectious Disease, 41(3), 376-85.
3. Bachmann, L.H., Grimley, D.M., Waithaka, Y., et al. (2005). Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care. Sexually Transmitted Diseases, 32(1), 20-26.
4. Baez-Feliciano, D.V., Thomas, J.C., Gomez, M.A., et al. (2005). Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Pan American Journal of Public Health, 17(2), 92-101.
5. Baggaley, R.F., Ferguson, N.M., & Garnett, G.P. (2005). The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerging Themes in Epidemiology, 2, 9.
6. Bateganya, M., Colfax, G., Shafer, L.A., et al. (2005). Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care and STDs, 19(11), 760-68.
7. Batterham, P., Rice, E., & Rotheram-Borus, M.J. (2005). Predictors of serostatus disclosure to partners among young people living with HIV in the pre- and post-HAART eras. AIDS and Behavior, 9(3), 281-87.
8. Blower, S., Bodine, E., Kahn, J., et al. (2005). The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS, 19(1), 1-14.
9. Boily, M.C., Bastos, F.I., Desai, K., et al. (2004). Changes in the transmission dynamics of the HIVepidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sexually Transmitted Diseases, 31(2), 100-13.
10. Boily, M.C., Godin, G., Hogben, M., et al. (2005). The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men. Medical Hypotheses, 65(2), 215-26.
11. Bouhnik, A.D., Moatti, J.P., Vlahov, D., et al. (2002). Highly active antiretroviral treatment does not increase sexual risk behavior among French HIV infected injecting drug users. Journal of Epidemiology and Community Health, 56(5), 349-53.
12. Bunnell, R., Ekwaru, J.P., Solberg, P., et al. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85-92.
13. Castilla, J., Del Romero, J., Hernando, V., et al. (2005). Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndrome, 40(1), 96-101.
14. Catz, S.L., Meredith, K.L., & Mundy, L.M. (2001). Women's HIV transmission risk perceptions and behaviors in the era of potent antiretroviral therapies. AIDS Education and Prevention, 13(3), 239-51.
15. Chen, S.Y., Gibson, S., Katz, M.H., et al. (2002). Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001. American Journal of Public Health, 92(9), 1387-88.
16. Chulamokha, L., DeSimone, J.A., & Pomerantz, R.J. (2005). Antiretroviral therapy in the developing world. Journal of Neurovirology, 11 (Suppl 1), 76-80.
17. Colebunders, R., Verdonck, K., Nachega, J., et al. (2000). Impact of new developments in antiretroviral treatment on AIDS prevention and care in resource-poor countries. AIDS Patient Care and STDs, 14(5), 251-57.
18. Crepaz, N., Hart, T.A., & Marks, G. (2004). Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. Journal of the American Medical Association, 292(2), 224-36.
19. Crepaz, N., & Marks, G. (2002). Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS, 16(2), 135-49.
20. Demmer, C. (2002). Impact of improved treatments on perceptions about HIV and safer sex among inner-city HIV-infected men and women. Journal of Community Health, 27(1), 63-73.
21. DeNoon, D.J. (1999). Conference coverage (HIV prevention); HAART optimism linked to high-risk behavior. AIDS Weekly Plus , Sept 20, 3-4.
22. Des Jarlais, D.C., Lyles, C., Crepaz, N., et al. (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. American Journal of Public Health, 94(3), 361-66.
23. Diamond, C., Richardson, J.L., Milam, J., et al. (2005). Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. Journal of Acquired Immune Deficiency Syndrome, 39(2), 211-18.
24. DiClemente, R.J., Funkhouser, E., Wingood, G., et al. (2002). Protease inhibitor combination therapy and decreased condom use among gay men. Southern Medical Journal, 95(4), 421-25.
25. Dukers, N.H.T.M., Goudsmit, J., de Wit, J.B.F., et al. (2001). Sexual risk behavior relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15(3), 369-78.
26. Elford, J., & Hart, G. (2005). HAART, viral load and sexual risk behaviour. AIDS, 19(2), 205-7.
27. Erbelding, E.J., Stanton, D., Quinn, T.C., et al. (2000). Behavioral and biologic evidence of persistent high-risk behavior in an HIV primary care population. AIDS, 14(3), 297-301.
28. Fang, C.T., Hsu, H.M., Twu, S.J., et al. (2004). Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. Journal of Infectious Diseases, 190(5), 879-85.
29. Gray, R.H., Li, X., Wawer, M.J., et al. (2003). Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS, 17(13), 1941-51.
30. Halkitis, P.N., Shrem, M.T., Zade, D.D., et al. (2005). The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy. Journal of Health Psychology, 10(3), 345-58.
31. Hogan, D.R., Baltussen, R., Hayashi, C., et al. (2005). Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. British Medical Journal , 331(7530), 1431-37.
32. Hosseinipour, M., Cohen, M.S., Vernazza, P.L., et al. (2002). Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clinical Infectious Diseases, 34(10), 1391-95.
33. International Collaboration on HIV Optimism. (2003). HIV treatments optimism among gay men: an international perspective. Journal of Acquired Immune Deficiency Syndrome, 32(5), pp. 545-50.
34. Jelsma, J., Maclean, E., Hughes, J., et al. (2005). An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care, 17(5), 579-88.
35. Katz, M.H., Schwarcz, S.K., Kellogg, T.A., et al. (2002). Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. American Journal of Public Health, 92(3), 388-94.
36. Kelly, J.A., Hoffman, R.G., Rompa, D., et al. (1998). Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS, 12(10), F91-F95.
37. Kelly, J.A., Otto-Salaj, L.L., Sikkema, K.J., et al. (1998). Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17(4), 310-19.
38. Laporte, A. (2002). A new decline in preventive behaviours among homosexual men: the role of highly active antiretroviral therapy? Eurosurveillance, 7(2), 15-16.
39. Lightfoot, M., Swendeman, D., Rotheram-Borus, M.J., et al. (2005). Risk behaviors of youth living with HIV: pre- and post-HAART. American Journal of Health Behavior, 29(2), 162-71.
40. Miller, M., Meyer, L., Boufassa, F., et al. (2000). Sexual behavior changes and protease inhibitor therapy. AIDS, 14(4), F33-F39.
41. Misovich, S.J., Fisher, J.D., & Fisher, W.A. (1999). Belief in a cure for HIV infection associated with greater HIV risk behaviour among HIV positive men who have sex with men. Canadian Journal of Human Sexuality, 8(4), 241-48.
42. Moatti, J.P., Prudhomme, J., Traore, D.C., et al. (2003). Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte d'Ivoire. AIDS, 17 (Suppl 3), S69-S77.
43. Mocroft, A., Velia, S., Benfield, T.L., et al. (1998). Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet, 352, 1725-30.
44. Munoz-Laboy, M., Castellanos, D., & Westacott, R. (2005). Sexual risk behaviour, viral load, and perceptions of HIV transmission among homosexually active Latino men: an exploratory study. AIDS Care, 17(1), 33-45.
45. Mussico, M., Lazzarin, A., Nicolosi, A., et al. (1994). Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Archives of Internal Medicine, 154(17), 1971-76.
46. Nollen, N.L., Goggin, K., Heiland, M.F., et al. (2002). The impact of combination therapy on the health behaviors of HIV+ gay men. AIDS and Behavior, 6(2), 131-39.
47. Ostrow, D.E., Fox, K.J., Chmiel, J.S., et al. (2002). Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS, 16(5), 775-80.
48. Palella, F.J. Jr, Delaney, K.M., Moorman, A.C., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-60.
49. Remien, R.H., Halkitis, P.N., O'Leary, A., et al. (2005). Risk Perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS and Behavior, 9(2), 167-76.
50. Remien, R.H., Wagner, G., Carballo-Dieguez, A., et al. (1998). Who may be engaging in high-risk sex due to medical treatment advances? AIDS, 12(12), 1560-61.
51. Rietmeijer, C.A., Patnaik, J.L., Judson, F.N., et al. (2003). Increases in gonorrhea and sexual risk behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health Clinic. Sexually Transmitted Diseases, 30(7), 562-67.
52. Rothenberg, R., Campos, P.E., del Rio, C., et al. (2003). Once and future HIV treatment: a comparison of clinic and community groups. International Journal of STD & AIDS, 14(7), 438-47.
53. Stephenson, J.M., Imrie, J., Davis, M.M.D., et al. (2003). Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection? Sexually Transmitted Diseases, 79(1), 7-10.
54. Stolte, I.G., Dukers, N.H.T.M., Geskus, R.B., et al. (2004). Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS, 18(2), 303-9.
55. Teixeira, P.R., Vitória, M.A., & Barcarolo, J. (2004). Antiretroviral treatment in resource-poor settings: the Brazilian experience. AIDS, 18(Suppl 3), S5-S7.
56. Tun, W., Gange, S.J., Vlahov, D., et al. (2004). Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases , 38(8), 1167-74.
57. Valdiserri, R.O. (2004). Mapping the roots of HIV/AIDS complacency: implications for program and policy development. AIDS Education and Prevention, 16(5), 426-39.
58. Vanable, P.A., Ostrow, D.G., McKirnan, D.J., et al. (2000). Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychology, 19(2), 134-35.
59. van der Snoek, E.M., de Wit, J., Mulder, P., et al. (2005). Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sexually Transmitted Diseases, 32(3), 170-75.
60. van der Straten, A. (1998). The effects of new treatments on sexual risk taking. Focus , 13(8), 5-6.
61. van der Straten, A., Gómez, C.A., Saul, J., et al. (2000). Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS, 14(4), F47-F54.
62. Van de Ven, P., Mao, L., Fogarty, A., et al. (2005). Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS, 19(2), 179-84.
63. Vlahov, D., Safaien, M., Lai, S., et al. (2001). Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS, 15(17), 2311-16.
64. Williamson, L.M., & Hart, G.J. (2004). HIV optimism does not explain increases in high-risk sexual behaviour among gay men in Scotland. AIDS, 18(5), 834-35.
65. Wood, E., Braitstein, P., Montaner, J.S., et al. (2000). Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet, 355(9221), 2095-2100.
66. World Bank. Countries and Regions. Retrieved December 12, 2005 from http://www.worldbank.org/
67. Xiridou, M., Geskus, R., de Wit, J., et al. (2003). The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS, 17(7), 1029-38.